Literature DB >> 8922797

Paracoccidioidomycosis: case report and review.

B J Manns1, B W Baylis, S J Urbanski, A P Gibb, H R Rabin.   

Abstract

A previously well 59-year-old man presented with paracoccidioidomycosis, more than 15 years after leaving South America. He failed to respond to conventional therapies, first with oral itraconazole and then with amphotericin B plus sulfadiazine, and eventually died of recurrent arterial emboli possibly due to paracoccidioidomycotic aortitis. This patient's presentation demonstrates the difficulties that may be encountered in diagnosing and managing this disease. Paracoccidioidomycosis should be suspected in patients with an appropriate travel history who experience weight loss and have pulmonary, mucosal, and cutaneous lesions. This article comprehensively reviews the literature, with emphasis on epidemiology, clinical presentation, diagnosis, and therapy with imidazole antifungal medications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922797     DOI: 10.1093/clinids/23.5.1026

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Drugs for treating paracoccidioidomycosis.

Authors:  V M Menezes; B G O Soares; C J F Fontes
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Chronic paracoccidioidomycosis in a female patient in Austria.

Authors:  A Mayr; M Kirchmair; J Rainer; R Rossi; A Kreczy; K Tintelnot; M P Dierich; C Lass-Flörl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

Review 4.  Hormones and the resistance of women to paracoccidioidomycosis.

Authors:  Jata Shankar; Angela Restrepo; Karl V Clemons; David A Stevens
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Genitourinary paracoccidioidomycosis complicated with urinary outflow obstruction-a report of two cases and a review of the literature.

Authors:  Paulo Henrique Goulart Fernandes Dias; Marcelo Zeni; Guilherme R Taques; Frederico R Romero; Fernando Henrique Tremel Bueno; Luiz Carlos Almeida Rocha
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiagnosis of paracoccidioidomycosis.

Authors:  B L Ortiz; S Díez; M E Urán; J M Rivas; M Romero; V Caicedo; A Restrepo; J G McEwen
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

7.  Infectious granulomatous laryngitis: a retrospective study of 24 cases.

Authors:  Leonardo Silva; Edward Damrose; Fernanda Bairão; Mayra L Della Nina; James C Junior; Henrique Olival Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06       Impact factor: 2.503

8.  Cell organisation, sulphur metabolism and ion transport-related genes are differentially expressed in Paracoccidioides brasiliensis mycelium and yeast cells.

Authors:  Rosângela V Andrade; Hugo C Paes; André M Nicola; Maria José A de Carvalho; Ana Lúcia Fachin; Renato S Cardoso; Simoneide S Silva; Larissa Fernandes; Silvana P Silva; Eduardo A Donadi; Elza T Sakamoto-Hojo; Geraldo A S Passos; Célia M A Soares; Marcelo M Brígido; Maria Sueli S Felipe
Journal:  BMC Genomics       Date:  2006-08-14       Impact factor: 3.969

9.  Thinking in paracoccidioidomycosis: a delayed diagnosis of a neglected tropical disease, case report and review of clinical reports and eco-epidemiologic data from Colombia since the 2000.

Authors:  Deving Arias Ramos; John Alexander Alzate; Ángela María Giraldo Montoya; Yessica Andrea Trujillo; Leidy Yurany Arias Ramos
Journal:  BMC Infect Dis       Date:  2020-02-10       Impact factor: 3.090

10.  Cutaneous Paracoccidioidomycosis.

Authors:  Juan Carlos Cataño; Milena Morales
Journal:  Am J Trop Med Hyg       Date:  2015-09       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.